How Well Heart Patients in Intensive Care Take Their Medicines
Looks at medicine use and beliefs in hospitalized people with heart failure or atrial fibrillation.
Key facts
- Who runs it
- AlFayhaa General Hospital
- Where
- Nasiriyah, IraqSee the 2 sites
- Trial code
- Registry title
- Assessment of Medication Adherence in Ccu Admitted Patients
- Status
- Not yet recruiting
- People taking part
- 250 people, planned
- Started
- 1 Mar 2026
- Planned end
- 1 Aug 2026
- Type of study
- Observational
- Treatments tested
- No intervention (observational study)
- Record updated
- 31 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with atrial fibrillation or heart failure who are in the coronary care unit and are clinically stable. They must be able to give informed consent.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Atrial fibrillation or heart failure; admitted to the coronary care unit; clinically stable at the time of interview.
Main reasons for not taking part
- Significant cognitive impairment
- Communication difficulties that prevent an interview
- A diagnosed psychiatric disorder that interferes with taking part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adult patients aged 18 years or older
- Diagnosed with atrial fibrillation or heart failure
- Admitted to the coronary care unit
- Clinically stable at the time of interview
- Able to provide informed consent
Who cannot take part
- Significant cognitive impairment
- Diagnosed psychiatric disorder interfering with participation
- Communication difficulties preventing interview
Where in Iraq
- Al-Nasiriyah Heart CenterNasiriyah, IraqContact: Suror S Alsabbagh, Bachelor of PharmacyNo longer taking part
- Al-Nasiriyah Teaching HospitalNasiriyah, IraqContact: Suroor Alsabbagh, BPharmNo longer taking part
About the trial
What the trial wants to find out
This study aims to assess medication adherence and the appropriateness of prescribed medications among patients admitted to the Coronary Care Unit (CCU). The study will use the Medication Appropriateness Index (MAI) to evaluate the suitability of prescribed medications and the Beliefs about Medicines Questionnaire (BMQ) to assess patients' beliefs and perceptions regarding their medications. Understanding medication adherence and related beliefs may help identify factors associated with inappropriate medication use and non-adherence in hospitalized cardiac patients. The findings of this study may contribute to improving medication management and patient care in the CCU setting.
The group in the trial
- CCU HF and AF Patients
Adult patients aged 18 years or older diagnosed with atrial fibrillation or heart failure and discharged from the coronary care unit.
Treatment: No intervention (observational study)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Assessment of Medication Adherence in Ccu Admitted Patients
- Plain-language title
- How Well Heart Patients in Intensive Care Take Their MedicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 31 March 2026